Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors

Affiliations

¹ Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Florence, Italy.
² IBMM, University Montpellier, CNRS, ENSCM, Montpellier, France.
³ Latvian Institute of Organic Synthesis, Riga, Latvia; Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.
⁴ Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, University Campus, Monserrato, Cagliari, Italy.
⁵ Department of Pharmaceutical Chemistry and Scientific Research and Innovation Support Unit, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
⁶ Institute of Biosciences and Bioresources, National Research Council, Napoli, Italy.
⁷ Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
⁸ School of Chemistry, University of New South Wales, Sydney, Australia.
⁹ Department of Integrative Oncology, BC Cancer Research Center, Vancouver, British Columbia, Canada.
¹⁰ Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Florence, Italy. Electronic address: claudiu.supuran@unifi.it.

PMID: 33296668
PMCID: PMC7820713
DOI: 10.1016/j.bpj.2020.11.011

Editorial

Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors

Andrea Angeli et al. Biophys J. 2021.

. 2021 Jan 5;120(1):178-181.

doi: 10.1016/j.bpj.2020.11.011. Epub 2020 Dec 8.

Authors

Affiliations

¹ Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Florence, Italy.
² IBMM, University Montpellier, CNRS, ENSCM, Montpellier, France.
³ Latvian Institute of Organic Synthesis, Riga, Latvia; Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.
⁴ Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, University Campus, Monserrato, Cagliari, Italy.
⁵ Department of Pharmaceutical Chemistry and Scientific Research and Innovation Support Unit, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
⁶ Institute of Biosciences and Bioresources, National Research Council, Napoli, Italy.
⁷ Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
⁸ School of Chemistry, University of New South Wales, Sydney, Australia.
⁹ Department of Integrative Oncology, BC Cancer Research Center, Vancouver, British Columbia, Canada.
¹⁰ Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Florence, Italy. Electronic address: claudiu.supuran@unifi.it.

PMID: 33296668
PMCID: PMC7820713
DOI: 10.1016/j.bpj.2020.11.011

No abstract available

PubMed Disclaimer

Comment in

Comments to the Editor Due to the Response by the Supuran Group to Our Article.
Jonsson BH, Liljas A. Jonsson BH, et al. Biophys J. 2021 Jan 5;120(1):182-183. doi: 10.1016/j.bpj.2020.11.012. Epub 2020 Dec 13. Biophys J. 2021. PMID: 33308476 Free PMC article. No abstract available.

Comment on

Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors.
Jonsson BH, Liljas A. Jonsson BH, et al. Biophys J. 2020 Oct 6;119(7):1275-1280. doi: 10.1016/j.bpj.2020.08.020. Epub 2020 Aug 27. Biophys J. 2020. PMID: 32910900 Free PMC article. Review.

References

1. Jonsson B.H., Liljas A. Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors. Biophys. J. 2020;119:1275–1280. - PMC - PubMed
1. Bozdag M., Ferraroni M., Supuran C.T. Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells. Eur. J. Med. Chem. 2019;182:111600. - PubMed
1. Moi D., Nocentini A., Onnis V. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation. Eur. J. Med. Chem. 2019;182:111638. - PubMed
1. De Luca L., Mancuso F., Gitto R. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases. Eur. J. Med. Chem. 2018;143:276–282. - PubMed
1. Fragai M., Comito G., Nativi C. Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) J. Med. Chem. 2017;60:9003–9011. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors

Affiliations

Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors

Authors

Affiliations

Comment in

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources